Приказ основних података о документу

dc.creatorBajić, Vladan
dc.creatorPotparević, Biljana
dc.creatorŽivković, Lada
dc.creatorBonda, David J.
dc.creatorSiedlak, Sandra L.
dc.creatorCasadesus, Gemma
dc.creatorLee, Hyoung-Gon
dc.creatorSmith, Mark A.
dc.date.accessioned2019-09-02T11:17:08Z
dc.date.available2019-09-02T11:17:08Z
dc.date.issued2009
dc.identifier.issn0306-9877
dc.identifier.urihttps://farfar.pharmacy.bg.ac.rs/handle/123456789/1212
dc.description.abstractPremature centromere division, or premature centromere separation (PCS), occurs when chromatid separation is dysfunctional, occurring earlier than usual during the interphase stage of mitosis. This phenomenon, seen in Robert's syndrome and various cancers, has also been documented in peripheral as well as neuronal cells of Alzheimer's disease (AD). In the latter instances, fluorescent in situ hybridization (FISH), applied to the centromere region of the X-chromosome in interphase nuclei of lymphocytes from peripheral blood in AD patients, demonstrated premature chromosomal separation before mitotic metaphase directly after completion of DNA replication in G(2) phase of the cell cycle. Furthermore, and perhaps unexpectedly given the presumptive post-mitotic status of terminally differentiated neurons, neurons in AD patients also showed significantly increased levels of PCS of the X-chromosome. Taken together with other phenomena such as cell cycle re-activation and ectopic re-expression of cyclins and cyclin dependent proteins, we propose that AD is an oncogenic phenotype leading to accelarated aging of the affected brain.en
dc.publisherChurchill Livingstone, Edinburgh
dc.relationinfo:eu-repo/grantAgreement/MESTD/MPN2006-2010/143018/RS//
dc.rightsopenAccess
dc.sourceMedical Hypotheses
dc.titleThe X-chromosome instability phenotype in Alzheimer's disease: A clinical sign of accelerating aging?en
dc.typearticle
dc.rights.licenseARR
dcterms.abstractБајић, Владан; Цасадесус, Гемма; Лее, Хyоунг-Гон; Сиедлак, Сандра Л.; Потпаревић, Биљана; Живковић, Лада; Смитх, Марк A.; Бонда, Давид Ј.;
dc.citation.volume73
dc.citation.issue6
dc.citation.spage917
dc.citation.epage920
dc.citation.other73(6): 917-920
dc.citation.rankM23
dc.identifier.wos000272923000011
dc.identifier.doi10.1016/j.mehy.2009.06.046
dc.identifier.pmid19647374
dc.identifier.scopus2-s2.0-70450248506
dc.identifier.fulltexthttps://farfar.pharmacy.bg.ac.rs//bitstream/id/165/1210.pdf
dc.type.versionpublishedVersion


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу